Pricing
Cyanvac
Contact
No bio yet
Gary Titus
Chief Financial Officer
Helen Zhu
Vp, Controller
This person is not in any teams
This person is not in any offices
Cyanvac develops vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector.
Industries
Headquarters
Links
ECRI Institute
Deschutes Brewery
Steer Automotive Group
Clearwater Seafoods Inc
Closed Loop
View more